Cargando…
Diurnal fluctuation in the number of hypocretin/orexin and histamine producing: Implication for understanding and treating neuronal loss
The loss of specific neuronal phenotypes, as determined by immunohistochemistry, has become a powerful tool for identifying the nature and cause of neurological diseases. Here we show that the number of neurons identified and quantified using this method misses a substantial percentage of extant neu...
Autores principales: | McGregor, Ronald, Shan, Ling, Wu, Ming-Fung, Siegel, Jerome M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5453544/ https://www.ncbi.nlm.nih.gov/pubmed/28570646 http://dx.doi.org/10.1371/journal.pone.0178573 |
Ejemplares similares
-
Hypocretin (orexin) cell loss in Parkinson’s disease
por: Thannickal, Thomas C., et al.
Publicado: (2007) -
Hypocretin (orexin) and melanin concentrating hormone loss and the symptoms of Parkinson’s disease
por: Thannickal, Thomas C., et al.
Publicado: (2008) -
Orexin/Hypocretin and Histamine Cross-Talk on Hypothalamic Neuron Counts in Mice
por: Berteotti, Chiara, et al.
Publicado: (2021) -
Opiate anticipation, opiate induced anatomical changes in hypocretin (Hcrt, orexin) neurons and opiate induced microglial activation are blocked by the dual Hcrt receptor antagonist suvorexant, while opiate analgesia is maintained
por: McGregor, Ronald, et al.
Publicado: (2023) -
Editorial: Hypocretins/Orexins
por: López, Miguel, et al.
Publicado: (2020)